Dr Reddys Laboratories is currently trading at Rs. 2404.10, up by 2.45points or 0.10% from its previous closing of Rs. 2403.75 on the BSE.
The scrip opened at Rs. 2403.10 and has touched a high and low of Rs. 2425.00 and Rs. 2403.10 respectively. So far 5,136 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2545.00 on 31-Oct-2013 and a 52 week low of Rs. 1720.50 on 01-Mar-2013.
Last one week high and low of the scrip stood at Rs. 2466.90 and Rs. 2401.00 respectively. The current market cap of the company is Rs. 40,912 crore.
The promoters holding in the company stood at 25.52% while Institutions and Non-Institutions held 41.44% and 16.16% respectively.
The company has reported over 2-fold jump in its net profit at Rs 773.38 crore for the quarter as compared to Rs 363.03 crore for the same quarter in the previous year. Total income of the company has increased by 20.61% at Rs 2740.90 crore for quarter under review as compared to Rs 2272.44 crore for the quarter ended September 30, 2012.
On the consolidated basis, the group has registered a growth of 69.41% in net profit at Rs 690.25 crore as compared to Rs 407.44 crore in the same quarter previous year. Total income of the group rose 17.14% to Rs 3421.12 crore for quarter under review as against Rs 2920.49 crore in corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |